
36 – Audit Findings and Corrective and Preventive Actions (CAPA) (S18E4)
About this episode
This episode examines the critical steps that follow a GMP audit: analyzing findings and implementing corrective and preventive actions (CAPA). We explore how audit findings are categorized and prioritized, focusing on the potential impact on product quality and regulatory compliance. Learn about the importance of root cause analysis, delving deep to understand the underlying reasons behind identified issues.
We'll discuss the process of developing and implementing effective corrective actions to address immediate problems. Explore the role of preventive actions in mitigating future risks and fostering continuous improvement. Learn how a robust CAPA system, including ongoing monitoring and documentation, ensures sustained compliance with cGMP standards and drives a culture of quality within the organization.
Get every episode summarized
Each time From Concept to Medicine - A Comprehensive Drug Development Journey publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from From Concept to Medicine - A Comprehensive Drug Development Journey

21 Atorvastatin (S24E21)
From Concept to Medicine - A Comprehensive Drug Development Journey

185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The AL...
From Concept to Medicine - A Comprehensive Drug Development Journey

20 Liraglutide (S24E20)
From Concept to Medicine - A Comprehensive Drug Development Journey

18 Pioglitazone (S24E18)
From Concept to Medicine - A Comprehensive Drug Development Journey